LifeVantage shares surge 16.14% after-hours on Q1 results and strategic acquisition of LoveBiome.

LifeVantage Corporation (Nasdaq: LFVN) surged 16.14% in after-hours trading following the announcement of its Q1 fiscal 2026 results and a strategic acquisition. The company reported 0.7% year-over-year revenue growth to $47.6 million and net income of $0.17 per diluted share, exceeding prior-year figures. CEO Steve Fife highlighted the completion of the LoveBiome acquisition, positioning the company as a leader in natural GLP-1 activation and microbiome health. The integration of LoveBiome’s P84 product and consultant community is described as exceeding expectations, signaling potential for accelerated growth. Additionally, LifeVantage declared a $0.045 quarterly dividend and reiterated full-year guidance, reinforcing financial stability. The stock’s sharp post-market rally reflects optimism around the acquisition’s strategic value and the company’s expanding wellness ecosystem, despite modest top-line growth and margin pressures.